Search is Powered by Google
Immune System / Vaccines News

Biothera Develops New Method For Analyzing Beta Glucan Structure

Main Category: Immune System / Vaccines
Also Included In: Pharmacy / Pharmacist;  Pharma Industry / Biotech Industry
Article Date: 06 Oct 2008 - 1:00 PDT

email icon email to a friend   printer icon printer friendly   write icon view / write opinions   rate icon rate article
Current Article Ratings:

Patient / Public:not yet rated

Health Professional:5 stars

5 (1 votes)

Article Opinions: 0 posts

Biothera has developed a new analytical method to characterize a key structural attribute of beta 1,3/1,6 glucans, which will aid researchers developing this immune-enhancing carbohydrate for pharmaceutical applications.

The method was presented recently to scientists at both the International Carbohydrate Symposium in Oslo, Norway, and the American Chemical Society national meeting in Philadelphia.

Beta 1,3 glucans are polysaccharides known for their ability to enhance innate immune responses. Derived from the cell walls of yeast and fungi, beta glucans can vary in terms of molecular weight, frequency of side chain branching, and the length and composition of side chains. These structural variations may affect bioactivity.

"We believe our on-going analytical chemistry program will become the new gold standard for structural characterization of beta glucan," said Daniel Conners, Biothera chairman and founder. "It is critical to fully characterize these compounds to further our understanding of their bioactivity and, ultimately, enable the development of pharmaceuticals."

The Biothera method, which employs alkaline degradation, analyzes the length, distribution and composition of side chains that contribute to beta glucan's potency as an immune modulator. The presentation in Norway was entitled, "Analysis of Side Chain Lengths of Branched β-1,3-Glucans by Alkaline Degradation."

"The new assay reflects Biothera's position as a world leader in carbohydrate chemistry," said Mr. Conners. "We are committed to pioneering beta glucan technology."

About Biothera, the Immune Health Company

Biothera is a biotechnology company dedicated to improving immune health. The company is developing pharmaceuticals that engage the innate immune system to fight cancer. Biothera also manufactures and markets food-grade ingredients that support healthy immune function to the nutritional supplement, functional food, cosmetic and animal nutrition markets.

Biothera




Personalized Homepage Weekly Newsletters Daily News Alerts
Opioid Induced Constipation ADHD Anxiety Asthma Autism Cancer Diabetes Lung Cancer Lupus Medicare / Medicaid Obesity and BMI Pancreatic Cancer Stem Cells All 'What Is...' Articles All 'How To...' Articles

Ophthalmology Urology
About Us News Licensing Free Website Feeds Free Tools & Content Tell a Friend Accessibility Help / FAQ Article Submission Links Contact Us

add medical news today to your facebook
medical news gadget

Swine Flu Image

Swine Flu Updates

- Latest Swine Flu News
- What is Swine Flu?
- Map Of H1N1 Outbreaks
- Swine Flu - Top 20 FAQ
- Daily Email News Alerts
Stick with Medical News Today for the latest news updates on swine flu.


These are the most read articles from this news category for the last 6 months:
Top Article Star
Sanofi Aventis Invests 100 Million Euros In New Facility In Mexico To Produce Seasonaland Pandemic Influenza Vaccine
19 Mar 2009
Sanofi-aventis (EURONEXT: SAN and NYSE: SNY), announced the signing of an agreement with the Mexican authorities to build a 100 million euro facility to manufacture influenza vaccine in Mexico...


Naps Aren't Just for Kids Anymore
Naps Aren't Just for Kids Anymore

A power nap may be the answer to the mid-day slump. Research suggests naps improve productivity, mental function, and motor function. They also may improve cardiovascular health.

more videos are available in our health videos section.